ADAMOU VELHIMA, MSc, Ph.D. student.

ADAMOU VELHIMA is a dedicated researcher specialising in the molecular epidemiology of infectious diseases, with a particular focus on tuberculosis. A fervent advocate of evidence-based research and practice, ADAMOU VELHIMA bridges the gap between researchers, policy-makers, and the end beneficiaries of research to promote impactful, evidence-based solutions for the healthcare system.

ADAMOU VELHIMA has a master’s degree in Medical Bacteriology and Virology from the University of Ngaoundéré, Cameroon. He also obtained a degree in biomedical sciences from the Department of the same university. He is now pursuing a doctorate/PhD at the University of Maroua, Cameroon. His Ph.D. thesis focused on the molecular study of strains of the Mycobacterium Tuberculosis complex in northern Cameroon. In addition to these degrees, ADAMOU VELHIMA has taken various additional training courses, strengthening his expertise in areas such as medical analysis, clinical research, and quality management, among others.

ADAMOU VELHIMA is currently a researcher at the Institute for Medical Research and the Study of Medicinal Plants, part of Cameroon’s Ministry of Scientific Research and Innovation. He is actively involved in pioneering research into infectious diseases.

ADAMOU VELHIMA has extensive technical expertise encompassing medical analysis methods and clinical research approaches. He has expertise in statistical data analysis using tools such as R and Excel in experimental design, clinical trial organization, and manuscript writing.

ADAMOU VELHIMA, a very active author, has authored more than 10 peer-reviewed articles in prestigious journals such as the International Journal of Clinical Science and Medical Research, the Journal of Biosciences and Medicines, the International Journal of Nursing and Health Care Research, and the World Journal of Methodology. He focuses on crucial issues such as antimicrobial resistance, vaginosis and vaginal candidiasis, the extent of hepatitis C, the epidemiology of tuberculosis, and the profile of urinary tract bacterial infections.